TITLE

ORTHOVITA GETS NANO-PARTICLE STRUCTURED TECHNOLOGY PATENT

PUB. DATE
March 2002
SOURCE
Worldwide Biotech;Mar2002, Vol. 14 Issue 3, p6
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the patent received by Orthovita Inc. on its nano-structured technology
ACCESSION #
6397756

 

Related Articles

  • ORTHOVITA'S CORTOSS SYNTHETIC BONE FILLER MORE EFFECTIVE.  // Worldwide Biotech;Mar2003, Vol. 15 Issue 3, p3 

    Focuses on clinical studies which examined the efficacy of CORTOSS Synthetic Cortical Bone Void Filler, a biomaterial designed to replace and reinforce bone in the spine weakened by osteoporosis and metastatic disease, from Orthovita Inc.

  • ORTHOVITA SELLS BIOGRAN DENTAL LINE TO IMPLANT INNOVATIONS.  // Biotech Equipment Update;May2000, p5 

    Focuses on issues related to Orthovita Inc. in Malvern, Pennsylvania. Sale of Biogran dental grafting product line to Implant Innovations Inc.; Use of sale proceeds to enhance working capital for the commercialization of CORTOSS and VITOSS products; Reason for increase in 1999 net losses of...

  • ORTHOVITA COMPLETES RHAKOSS PILOT CLINICAL STUDY IN EUROPE.  // Worldwide Biotech;Oct2002, Vol. 14 Issue 10, p2 

    Reports that Orthovita Inc. has completed the initial clinical pilot study in Europe for RHAKOSS Synthetic Bone Spinal Implant.

  • Stockholders aim to block Stryker, Orthovita merger.  // Medical Device Daily;6/2/2011, Vol. 15 Issue 106, p3 

    The article reports on the plan of Orthovita stockholders to stop the 316 million U.S. dollars merger of the company with Stryker, which according to a lawsuit filed by the shareholders breaches the fiduciary duty of Orthovita.

  • AAOS notebook.  // Medical Device Daily;2/18/2011, Vol. 15 Issue 34, p2 

    The article reports that orthologics and biosurgery company Orthovita will launch Vitoss Bioactive Foam-2X Bone Graft Substitute, a non-structural bone void filler for use in the pelvis, extremities and posterolateral spine.

  • Styker completes $316M acquisition of Orthovita.  // Medical Device Daily;6/30/2011, Vol. 15 Issue 121, p2 

    The article announces the acquisition of Orthovita based in Pennsylvania by Michigan-based orthopedic device-maker Stryker.

  • UPDATE: Stryker Acquires Orthovita. Cody, Tamika // Mergers & Acquisitions Report;5/23/2011, Vol. 24 Issue 21, p23 

    The article deals with the acquisition of the common stocks owned by U.S. orthobiologics platform developer Orthovita by medical equipment and device developer Stryker Corp. in May 2011.

  • Angiotech: In No Hurry To Take Out Orthovita. Cohen, Judy Radler // Mergers & Acquisitions Report;6/20/2005, Vol. 18 Issue 24, p1 

    Reports on the decision of U.S. firm Angiotech Pharmaceuticals Inc. to delay its plan of acquiring Orthovita Inc. following the rejection of its offer by Orthovita Inc. Cash offer made by Angiotech Pharmaceuticals Inc.; Analysis of the merger and acquisition tactics of Angiotech...

  • Orthovita financings add $77M; crystalens maker files for IPO. Ford, Omar // Medical Device Daily;7/31/2007, Vol. 11 Issue 144, p1 

    The article reports on the equity offering of Malvern, Pennsylvania-based company Orthovita. The equity offering of the company amounts to $32.5 million. According to the company, proceeds will be used to commercially develop Cortoss, the bone augmentation product and the main revenue generator...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics